Mabion S.A. (MAB.WA)
Mabion S.A., a biopharmaceutical company, provides contract development, analytics, and manufacturing services for biologics in Poland.
7.46+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-22.9%
The outlook
Mabion S.A. currently reads as leaning bearish based on mixed vs its moving averages, 23% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Market cap
$120.6M
52-wk high
10.00
52-wk low
6.70
50-day avg
7.43
200-day avg
7.89
Trailing P/E
—